Cargando…
Data on impact of monocytes and glucose fluctuation on plaque vulnerability in patients with coronary artery disease
Data presented in this article are supplementary material to our research article entitled “Impact of CD14(++)CD16(+) monocytes on coronary plaque vulnerability assessed by optical coherence tomography in coronary artery disease patients” [1]. This article contains the data of study population, diag...
Autores principales: | Yamamoto, Hiroyuki, Yoshida, Naofumi, Shinke, Toshiro, Otake, Hiromasa, Kuroda, Masaru, Sakaguchi, Kazuhiko, Hirota, Yushi, Toba, Takayoshi, Takahashi, Hachidai, Terashita, Daisuke, Uzu, Kenzo, Tahara, Natsuko, Shinkura, Yuto, Kuroda, Kouji, Nagasawa, Yoshinori, Nagano, Yuichiro, Tsukiyama, Yoshiro, Yanaka, Ken-ichi, Emoto, Takuo, Sasaki, Naoto, Yamashita, Tomoya, Ogawa, Wataru, Hirata, Ken-ichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5996257/ https://www.ncbi.nlm.nih.gov/pubmed/29900190 http://dx.doi.org/10.1016/j.dib.2018.03.022 |
Ejemplares similares
-
Effects of daily glucose fluctuations on the healing response to everolimus-eluting stent implantation as assessed using continuous glucose monitoring and optical coherence tomography
por: Kuroda, Masaru, et al.
Publicado: (2016) -
Association between daily glucose fluctuation and coronary plaque properties in patients receiving adequate lipid-lowering therapy assessed by continuous glucose monitoring and optical coherence tomography
por: Kuroda, Masaru, et al.
Publicado: (2015) -
Impact of CD14(++)CD16(+) monocytes on plaque vulnerability in diabetic and non-diabetic patients with asymptomatic coronary artery disease: a cross-sectional study
por: Yoshida, Naofumi, et al.
Publicado: (2017) -
Impaired Cholesterol‐Uptake Capacity of HDL Might Promote Target‐Lesion Revascularization by Inducing Neoatherosclerosis After Stent Implantation
por: Nagano, Yuichiro, et al.
Publicado: (2019) -
Impact of daily glucose fluctuations on cardiovascular outcomes after percutaneous coronary intervention for patients with stable coronary artery disease undergoing lipid‐lowering therapy
por: Yamamoto, Hiroyuki, et al.
Publicado: (2020)